These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16474168)

  • 1. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.
    Fenton JI; Hord NG
    Carcinogenesis; 2006 May; 27(5):893-902. PubMed ID: 16474168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counterpoint: From animal models to prevention of colon cancer. Criteria for proceeding from preclinical studies and choice of models for prevention studies.
    Bruce WR
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):401-4. PubMed ID: 12750233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial prevention of carcinogenic risk in a model for familial colon cancer.
    Telang N; Katdare M
    Oncol Rep; 2007 Apr; 17(4):909-14. PubMed ID: 17342335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Context is everything: Mining the normal and preneoplastic microenvironment for insights into the diet and cancer risk conundrum.
    Hord NG; Fenton JI
    Mol Nutr Food Res; 2007 Jan; 51(1):100-6. PubMed ID: 17195262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New rodent models for studies of chemopreventive agents.
    Lipkin M
    J Cell Biochem Suppl; 1997; 28-29():144-7. PubMed ID: 9589360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal carcinogenesis: sequential steps in the in vitro immortalization and transformation of human colonic epithelial cells (review).
    Paraskeva C; Corfield AP; Harper S; Hague A; Audcent K; Williams AC
    Anticancer Res; 1990; 10(5A):1189-200. PubMed ID: 2241098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.
    Hursting SD; Nunez NP; Patel AC; Perkins SN; Lubet RA; Barrett JC
    Mutat Res; 2005 Aug; 576(1-2):80-92. PubMed ID: 15990122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies.
    Kim YI
    Environ Mol Mutagen; 2004; 44(1):10-25. PubMed ID: 15199543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronutrients as chemopreventive agents.
    Reddy BS
    IARC Sci Publ; 1996; (139):221-35. PubMed ID: 8923033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary agents in the chemoprevention of prostate cancer.
    Shukla S; Gupta S
    Nutr Cancer; 2005; 53(1):18-32. PubMed ID: 16351503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of carcinogenesis by protease inhibitors.
    Kennedy AR
    Cancer Res; 1994 Apr; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials.
    Hemstreet GP; Rao J; Hurst RE; Bonner RB; Waliszewski P; Grossman HB; Liebert M; Bane BL
    J Cell Biochem Suppl; 1996; 25():197-204. PubMed ID: 9027619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
    Slawin K; Kadmon D; Park SH; Scardino PT; Anzano M; Sporn MB; Thompson TC
    Cancer Res; 1993 Oct; 53(19):4461-5. PubMed ID: 8402613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifiability of food components for cancer chemoprevention.
    Riboli E; Slimani N; Kaaks R
    IARC Sci Publ; 1996; (139):23-31. PubMed ID: 8923017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.